Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452).

Source:http://linkedlifedata.com/resource/pubmed/id/18580611

AIDS 2008 Jul 11 22 11 1313-22

Download in:

View as

General Info

PMID
18580611